In a survey of health clinics participating in a new initiative to improve care for cardiovascular-kidney-metabolic (CKM) syndrome, most sites reported conducting basic screening for heart, kidney and metabolic risks. However, far fewer are using newer guideline-recommended tools such as the CKM syndrome staging framework and the American Heart Association's PREVENT (Predicting Risk of cardiovascular EVENT) equations, according to new, preliminary research presented at the American Heart Association's Scientific Sessions 2026, held Nov. 6–9 in Chicago.
Survey Reveals Gaps in Cardiovascular-Kidney-Metabolic Syndrome Care Tools
A survey of health clinics involved in a new initiative for cardiovascular-kidney-metabolic (CKM) syndrome care revealed that while basic screenings are common, the adoption of advanced tools like the CKM syndrome staging framework and PREVENT equations is lacking. This research was presented at the American Heart Association's Scientific Sessions 2026. The findings highlight potential gaps in healthcare practices that could impact patient outcomes in Iran.
👥 Key Players
📰 What Happened
A survey conducted among health clinics revealed that while basic screenings for cardiovascular-kidney-metabolic syndrome are common, the use of advanced care tools is lacking. This was presented at a major health conference in Chicago.
- Most clinics reported conducting basic screenings for CKM syndrome.
- Fewer clinics adopted advanced tools like CKM staging framework and PREVENT equations.
💡 Why It Matters
📚 Background
Cardiovascular-kidney-metabolic syndrome is a cluster of conditions that increase the risk of heart disease and other health issues. Effective management is crucial for improving patient outcomes.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%